CuroSygnal
durch Curo 46 LLC
AI risk prediction for rehospitalization. Patient-specific reasoning, real-time alerts.
Rehospitalizations drive Five-Star penalties, value-based purchasing risk, and post-acute margin compression. Many of them are predictable. CuroSygnal helps your team see the signals earlier.
CuroSygnal is clinical AI that surfaces residents with elevated risk indicators, 3 to 14 days before a potential admission. Your nurses see a short, prioritized list of the residents to review today, with the contributing clinical signals visible on every score.
Many early-warning tools generate alert noise that clinical teams learn to tune out, eroding trust in the signals that need attention. CuroSygnal is engineered differently: high signal-to-noise, with feature-level explainability that supports independent clinician review on every output.
The result: your nurses see which residents have elevated risk indicators, and the contributing clinical signals behind each score. Clear explainability supports confident clinical direction; every clinical decision stays with the team.
CuroSygnal predicts return to the hospital 3 to 14 days in advance, with up to 98% accuracy. Trend forecasting provides a potential explanation of patient decline and the contributing "triggering" observations behind each score.
In practice: when a resident's risk score crosses threshold, the day-shift charge nurse opens Hot Rack, reviews the contributing clinical signals, and brings the case to the morning huddle, days before a potential admission.
What your team gets
- Hot Rack ranked patient queue. Prioritized list of residents with elevated risk indicators, with the contributing clinical signals visible on every score.
- Engineered for clinical precision. High signal-to-noise, so the care team can trust what surfaces.
- 3 to 14 day forward-looking window. Lead time to review emerging risk signals before a potential admission.
- Feature-level explainable AI. Every risk score is traceable to the contributing clinical signals, supporting independent clinician review.
- Trend forecasting. Surfaces the contributing "triggering" observations behind a rising risk score.
- Census, payer, and role-based views. Live operational visibility across single or multi-facility deployments.
- Native to MatrixCare. Integrates with any EHR platform.
- Microsoft sign-in. Authenticate with your Microsoft identity.
Performance metrics
- Up to 98% accuracy on return-to-hospital prediction, 3 to 14 days in advance of admission.
- Up to 98.5% AUC (threshold-independent discrimination).
- Up to 98.7% sensitivity at the best operating threshold.
These figures reflect validation across multi-facility post-acute deployments.
Who it is built for
Built for the teams that carry rehospitalization risk: skilled nursing and post-acute networks, and the discharge teams inside acute hospitals.
Regulatory posture
CuroSygnal is a clinical decision support tool under the FDA CDS exemption (Sept 2022). Final clinical decisions remain with the licensed clinician.
Privacy and security
Demos run on Curo46-hosted fake patients and facilities. No PHI is exchanged in the sales cycle. Data is encrypted in transit and at rest. Business Associate Agreement (BAA) available for production deployment.
Book a 30-minute demo
The fastest way to evaluate CuroSygnal is to see the platform run on fake patients and facilities.
Or email sales@ggenomics.com. Response within one business day.